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Abstract
Maternal Diabetes is one of the most common metabolic disorders resulting an 
increased risk of abnormalities in the developing fetus and offspring. It is estimated 
that the prevalence of diabetes during pregnancy among women in developing 
countries is approximately 4.5 percent and this range varies between 1 to 14 percent 
in different societies. According to earlier studies, diabetes during pregnancy is 
associated with an increased risk of maternal and child mortality and morbidity as 
well as major congenital anomalies including central nervous system (CNS) in their 
offspring. Multiple lines of evidence have suggested that infants of diabetic women 
are at risk of having neurodevelopmental sequelae. Previous studies reveal that the 
offspring of diabetic mothers exhibit disturbances in behavioral and intellectual 
functioning. In the examination of cognitive functioning, a poorer performance 
was observed in the children born to diabetic mothers when compared with the 
children of non-diabetic mothers. Therefore, it is important to study the possible 
effects of maternal diabetes on the hippocampus of these infants.
Keywords: Maternal diabetes, Central nervous system, Hippocampus, 
Hyperglycemia
1. Introduction
1.1 Hippocampus
The hippocampus in humans is a part of the cortical region that is connected to 
the limbic system and consists of two cortical structures: the hippocampal forma-
tion and the parahippocampal region. Hippocampal formation refers to a group of 
structures with a unique cellular structure and arrangement that accompany the 
hippocampus and include: dentate gyrus, hippocampus, subiculum, presubiculum, 
and parasubiculum [1, 2]. The main difference between these two structures is the 
number of cortical layers and their general connections. The hippocampus in the 
coronal sections is a C-shaped structure located into the lower horn of the lateral 
ventricle. Its general shape is similar to a seahorse (Figure 1A) [3].
The most common classification for the hippocampus in non-human primates 
and other laboratory animals is, the hippocampus is divided into 4 subfields, 
CA1-CA4. In humans, most parts of the hippocampal formation are located on 
the floor of the temporal horn of the lateral ventricle (Figure 1B). The part of the 
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hippocampus that is located in the floor of the lateral ventricular temporal horn 
(most parts of CA1 and CA2 and the distal part of CA3) is about 4 cm long [1].
1.1.1 Evolution of hippocampal formation in humans
By the ninth week of pregnancy, the primary hippocampus develops within the 
cerebral hemispheres but does not resemble an adult hippocampus. At the middle 
of the third trimester of pregnancy (weeks 19–15), immature dentate gyrus, the 
subiculum, and different areas of the hippocampus can be identified. The hippo-
campal groove deepens and different areas of the hippocampus appear to be more 
developed, at the end of the 25th week of pregnancy. Although cell layers are more 
pronounced in CA1 and CA2-CA3; But the boundary between CA1 and subiculum 
is not clear. By the last trimester of pregnancy (34 weeks), the hippocampal groove 
is narrower and the boundary between CA1 and subiculum is distinguishable; 
CA1, CA2, and CA3 are recognizable and seem the dentate gyrus has a mature 
appearance.
It should be noted that a decrease in hippocampal cell density is observed in the 
postnatal period, which is probably due to the apoptosis and the growth of neurons 
and filaments. No significant morphological changes are seen until puberty and, 
and the only myelination is gradually completed [4, 5].
1.1.2 Hippocampal functions
The first theory suggested that the hippocampus has a key role in olfactory func-
tions. But this theory was not accepted because Studies in later years showed that 
the hippocampus did not receive any nerve fibers directly from the olfactory bulb; 
However, the further study indicated that the hippocampus may be involved in 
olfactory responses, and in particular in olfactory memory [6]. In addition, Jeffrey 
Gray suggested that the hippocampus might play a role in anxiety [7].
Years later, three main ideas for hippocampal function were explained: response 
inhibition, learning and memory, and spatial cognition [8]. The majority of psy-
chologists and neuroanatomists believe that the hippocampus plays a principal role 
in the formation of new memories about experienced events (episodic or autobio-
graphical memory), which is part of the role of the hippocampus in its activity in 
discovering new events, places, and stimuli [9, 10]. Some researchers believe that 
the hippocampus is responsible for declarative memory in addition to episodic 
memory [11, 12]. Severe damage to the hippocampus can cause problems with 
the formation of new memory, as well as impairment of earlier formed memory. 
Figure 1. 
Isolated hippocampus of human which is similar to seahorse (A). The shape and location of the hippocampus 
in humans (B).
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However, the memory from years before the hippocampal injury may remain intact, 
which appears to be due to the transfer of memory from the hippocampus to other 
parts of the brain over the years [8].
Interestingly, damage to the hippocampus does not affect some types of mem-
ory, such as motor memory and the ability to learn new motor and cognitive skills, 
such as playing a musical instrument and solving a variety of tables. This implies 
that these abilities depend on other types of memory called working memory, 
which involve different areas of the brain [13]. Several researchers distinguish 
between conscious recollection and familiarity which depends on the hippocampus 
and portions of the medial temporal lobe, respectively [14]. The hippocampus 
and related areas are necessary for the systematic formation and organization of 
memory, their retrieval, and the repetition of learned experiences. Hippocampal 
neurons encode a large amount of information received in the form of senses and 
experiences and are implicitly organized [9].
The hippocampal/internal temporal lobe (HC/MTL) complex seems to be neces-
sary for the formation of spatial memory. This memory requires the interpretation 
and processing of sensory information received from the environment. In mammals 
in general, the proper functioning of the hippocampus, especially CA1, is essential 
for the formation and processing of space-related memory. Evidence suggests 
that the right hippocampus in humans plays a key role in spatial memory, and in 
rodents, the amount and accuracy of spatial memory are directly related to the 
number of hippocampal mossy fibers [15–17].
1.2 Diabetes
According to the World Health Organization (WHO), the term diabetes 
mellitus refers to a metabolic disorder with a variety of causes, including chronic 
hypoglycemia and impaired metabolism of carbohydrates, fats, and proteins 
due to impaired insulin secretion, insulin function, or both. Diabetes mellitus 
can have long-term effects and involve a variety of organs, including the central 
and peripheral nervous system, cardiovascular system, kidneys, and muscles. 
According to the World Health Organization, approximately 347 million people 
worldwide suffer from diabetes. However, 80% of these patients live in develop-
ing countries, and this number is increasing day by day [18, 19]. In addition, 
the number of people suffering from this metabolic disease in 2000 was 171 
million, which will increase to 366 million in 2030 if proper prevention and 
treatment strategies are not implemented [20]. It is also estimated that by 2050 
the incidence of diabetes in the world will increase by 198%, which will have 
a significant impact on increasing health care costs [20, 21]. As well as, global 
estimates suggest that by 2030, most people with diabetes will be 45 to 64 years 
old. The prevalence of type 2 diabetes is much faster than type 1, due to the 
increasing prevalence of obesity and reduced physical activity, which is one of the 
 consequences of the industrialization of countries [22].
1.2.1 Diabetes can be divided into three general categories
1.2.1.1 Type 1 diabetes (T1D)
Type 1 diabetes, or insulin-dependent diabetes, is caused by the destruction of 
pancreatic beta cells as a result of insufficient insulin release. This type of diabetes 
is most common in adolescence and young adulthood and accounts for 10% of all 
diabetes cases [23].
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1.2.1.2 Type 2 diabetes (T2D)
Type 2 or non-insulin-dependent diabetes, which is more common than type 1 
diabetes, occurs due to insensitivity and resistance to insulin in the body along with 
insufficient insulin release. This type of diabetes is more common in the elderly, 
especially women [22].
1.2.1.3 Gestational diabetes mellitus (GDM)
Gestational diabetes mellitus is another type of diabetes that can be diagnosed 
during pregnancy and is defined as any amount of glucose intolerance that develops 
or is first diagnosed during pregnancy. However, in most cases, it is type 2 diabetes, 
which obviously leads to type 2 diabetes in 30 to 50 percent and in some cases has a 
similar course to type 1 diabetes [24]. According to this issue, diabetics and preg-
nant people can be divided into two groups: a group of people with diabetes who 
had diabetes before pregnancy (pre-existing diabetes) and may have one type of 
diabetes (T1D or T2D); The second group of people in whom gestational diabetes is 
diagnosed for the first time during pregnancy [25, 26].
1.2.2 Diabetes during pregnancy
Diabetes mellitus is the most common and important metabolic complication in 
pregnancy that can affect maternal and fetal health [27]. According to studies, dia-
betes is seen in around 7% of pregnancies and its prevalence depends on the study 
population and diagnostic tests from 1 Up to 14% have also been reported [24, 28]. 
Gestational diabetes is one of the leading causes of mortality in pregnant women 
which can be elevating the risk for spontaneous abortion, stillbirth, congenital 
malformations, and perinatal morbidity and mortality [29]. It is well documented 
that maternal glycemic control during pregnancy can markedly decrease congeni-
tal malformation outcomes in the fetus. Studies have shown that infants born to 
diabetic mothers have a higher risk of congenital disorders in the nervous, cardio-
vascular, kidney, and gastrointestinal tracts [26, 30–32].
1.2.2.1 Pathophysiology of gestational diabetes on embryonic development
In healthy mothers and under normal conditions, pregnancy causes hyperplasia 
of pancreatic beta cells and increases insulin levels in the mother’s bloodstream [33]. 
On the other hand, at the beginning of pregnancy, insulin sensitivity is observed in 
pregnant women, which turns into insulin resistance as the pregnancy progresses. 
Maternal insulin resistance appears to occur due to the production of placental 
diabetogenic hormones such as growth hormone, placental lactogen, corticotropin-
releasing hormone, and progesterone [33, 34]. This insulin resistance decreases 
after the placenta leaves the mother’s body and increases the risk of hyperglycemia 
in mothers 7 to 15 weeks after delivery [35, 36].
Previous studies have illustrated that increase in the level of maternal blood 
glucose and a decrease in insulin is the main reason for diabetes during pregnancy 
[37]. In the above conditions, glucose can easily pass through the placenta into the 
fetal bloodstream, leading to fetal hyperglycemia. During the first few weeks of 
pregnancy, fetal islet cells (beta cells) cannot release enough insulin in response to 
hyperglycemia, which is the main cause of fetal hyperglycemia. In response to this 
condition, after week 20, the fetal pancreas is stimulated and the pancreatic beta 
cells begin to hypertrophy and hyperplasia, which eventually leads to increased 
fetal insulin levels. In addition to impairing the development of various organs, this 
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complication can be followed by hypoglycemia and hyperinsulinemia in the first 
few days after birth [30, 37–39].
Results from previous experiments have shown that insulin can influence 
carbohydrate, fats, and protein metabolism, membrane transport of glucose, amino 
acids, and ion exchange in cells as well as protein and DNA synthesis. In addition, 
insulin can stimulate or inhibit the activity of certain enzymes and regulate gene 
expression [40]. On the other hand, alters and reduction of ions transfer can lead to 
the reduction level of some vital ions such as zinc. Thereby, this process has a nega-
tive effect on the migration of marginal layer cells in the fetus of diabetic mothers 
which increases defects in the central nervous system [41]. In this regard, some 
studies indicate that high concentrations of beta-hydroxybutyric acid, which occurs 
in diabetes mothers, can delay the development of the central nervous system of the 
fetus [42–44].
Although hyperglycemia is believed to be the most important teratogenic element 
in diabetic pregnancy; Some researchers suggest that changes in maternal metabolic 
status (i.e., triglyceride and β-hydroxybutyrate levels and branched-chain amino 
acids) lead to disrupted fetal metabolism of inositol, sorbitol, prostaglandins, and 
arachidonic acid could have a teratological effect and therefore be important for the 
incidence of fetal disorders. An excess of fetal reactive oxygen species (ROS) has also 
been linked to the etiology of congenital malformations induced by diabetes. These 
free radicals may cause increasing neuronal death by oxidizing proteins, damaging 
DNA, and inducing the lipoperoxidation of cellular membranes. In vitro and in vivo 
studies have shown that the disturbed development of embryos in a diabetic milieu 
can be normalized by treatment with different antioxidant factors [27, 45–47].
1.2.3 The effects of gestational diabetes on fetal development and infant health
It is well documented that fetuses of mothers with diabetes during pregnancy 
are in a completely different environment than a healthy mother. Glucose, alanine, 
and free fatty acids are transported in large quantities from the mother’s blood to 
the fetus. As a result, the concentration of insulin in the amniotic fluid increased, 
which indicates a compensatory response of the fetus to an increase in these factors 
[48]. Hyperglycemia in the first trimester of pregnancy increases significantly the 
risk of congenital malformations and stillbirth [49].
Several studies have shown that maternal hyperglycemia during pregnancy 
causes fetal hyperglycemia and neonatal hypoglycemia; Because circulating glucose 
simply crosses the placenta by facilitating diffusion, resulting in fetal hyperglyce-
mia [35, 37]. In contrast, to compensate for this event, the fetal pancreas is stimu-
lated and the pancreatic beta cells begin to hypertrophy, which causes increased 
fetal insulin levels. Due to the inability of the growing beta cells in the pancreas to 
secrete enough insulin, this condition soon leads to fetal hypoinsulinemia [37, 50]. 
Although this complication is temporary; However, studies show that fetuses from 
mothers with diabetes develop hyperinsulinemia in the last trimester of pregnancy. 
This condition in the fetus, in addition to affecting various organs, puts infants 
at risk for hypoglycemia in the few first days after birth, which is one of the most 
important causes of infant mortality in diabetic mothers [51, 52]. Previous studies 
report that gestational diabetes can increase the risk of impaired fetal and neonatal 
development, mortality, and also problems in infancy, childhood, and adulthood 
[31, 32]. Abundant human studies have identified type 1 diabetes during pregnancy 
as an important factor in the development of fetal and neonatal complications such 
as stillbirth, fetal macrosomia, respiratory distress syndrome, diabetes, jaundice, 
asphyxia, hypertension, neonatal hyperglycemia, hypocalcemia and hypomagnese-
mia, cardiac abnormalities, hypoxia, and neonatal polycythemia [53–55].
Hippocampus - New Advances
6
Studies have also shown that diabetes can have teratogenic effects and also nega-
tive effects on embryogenesis, organogenesis, and fetal growth [56]. The frequency 
of the mentioned problems is the same for both types of diabetes and the incidence 
of these complications depends directly on the severity of maternal diabetes 
[57]. Studies have shown that in gestational diabetes, there is a linear relationship 
between maternal glucose levels in early pregnancy and the incidence of birth 
defects [58].
1.2.3.1 Fetal and infant mortality
In past years, the rate of infant mortality from diabetic mothers has been signifi-
cantly high. But nowadays, due to advances in medical and obstetrical management 
in the pregnancy period, this rate has decreased significantly. But despite these 
advances, the mortality rate in these infants is still reported to be 3 to 10 times 
higher than in infants under normal pregnancy conditions, as well as the prevalence 
of congenital malformations is 4 to 10 times higher than that of healthy mothers 
[29, 33]. Studies show that fetal malformations are the reason 30 to 40 percent of 
infant deaths in diabetic mothers. However, it has been clearly shown that precise 
control of blood glucose during pregnancy reduces maternal and neonatal mortality 
[59, 60].
1.2.3.2 Neonatal hypoglycemia
A sharp drop in plasma glucose concentration after delivery is a characteristic 
feature of newborns born to poorly controlled diabetic mothers. This event occurs 
due to chronic maternal hyperglycemia resulting in fetal pancreatic cell hyperplasia. 
Subsequently, this hyperplasia causes stimulation of fetal pancreatic beta cells to 
release a high level of insulin. In addition to stimulating somatic growth, hyperinsu-
linemia is also one of the main causes of hypoglycemia in the first few minutes after 
birth [24, 49].
1.2.3.3 Congenital malformations
Fetal malformations, which usually occur between 7 and 10 weeks, account for 
30 to 40 percent of prenatal deaths. Studies show that the rate of severe malforma-
tions in children of healthy mothers is 7.8%, but 15% in children of diabetic moth-
ers. These malformations usually affect the central nervous system, heart, kidneys, 
and urinary system [27, 33].
1.2.3.4 Macrosomia
It is more common in infants of mothers with diabetes and increases the risk of 
death at birth. Diabetes during pregnancy can double the incidence of macrosomia 
and other neonatal anthropometric indexes in diabetic mothers compared to babies 
born to non-diabetic mothers. Previous studies have clearly established that mater-
nal diabetes can induce macrosomia in most fetal organs except the brain. These 
events are closely related to fetal hyperinsulinemia and maternal hyperglycemia 
[24, 61].
1.2.3.5 Neuropsychological effects of gestational diabetes on infants
Previous studies have shown that infants of diabetic mothers have a significant 
decrease in brain weight and size compared to healthy mothers [37]. Moreover, 
7
The Impact of Diabetes on Hippocampus
DOI: http://dx.doi.org/10.5772/intechopen.99895
multiple lines of evidence indicated that offspring of diabetic mothers exhibit dis-
turbances in behavioral and intellectual functioning. In this way, other studies have 
shown a link between brain size and intelligence. These children also show poorer 
cognitive function than children of healthy mothers, which is related to the effects 
of maternal metabolic changes on the development of the fetal central nervous 
system (CNS) [62–64]. Long-term studies of offspring born to diabetic mothers 
have shown that diabetes during pregnancy reduces IQ in these children [65].
Researchers believe that gestational diabetes is a teratogen for the development 
of the central nervous system [66]. Since the brain is one of the major organs using 
up glucose in the body, any defect in the process of supplying glucose to the brain, 
even for a short time, can cause brain disorders [67]. In humans, the differentiation 
and maturation of the cerebral cortex occur at the end of the second trimester of 
pregnancy, and therefore at this time, any change in blood glucose levels can have 
irreversible effects [65, 67, 68]. It is believed that hypoglycemia due to hyperinsu-
linemia in infants born to mothers causes neuronal damage in the internal temporal 
region and also memory-related areas [69].
Smoak and Sadler examined the role of glucose in brain development in mouse 
embryos. The researchers showed that a 50 percent reduction in blood glucose levels 
for 2 hours in mice at the stage of neural tube formation causes developmental 
disorders in the nervous system [70]. Habituation is a sign of proper functioning 
of the central nervous system. Studies have shown that fetuses of diabetic mothers 
have poorer habituation than fetuses of healthy mothers. This reduction is indica-
tive of the effect of gestational diabetes on suitable central nervous system function 
[62, 71].
1.2.3.6 Attention deficit disorder and hyperactivity
Neural damage in infants of mothers with diabetes during pregnancy is not only 
limited to a negative effect on their intelligence but also can reduce their concentra-
tion [65]. Studies have indicated a higher incidence of developmental delay and 
behavioral problems including short attention span, over-activity, and attention-
seeking in children born to mothers with diabetes [58]. Moreover, growth motor 
skills and speech and language delay were the main development areas of concern 
that could link between maternal diabetes and development in children aged 
1–6 years [72]. Other studies demonstrated that school-age children younger than 
9 years, born to diabetic mothers, had a higher rate of attention deficit, lower cogni-
tive scores, and lower gross and fine motor achievements than matched control 
children did. as well as the period might affect the later cognitive and behavioral 
function of progeny by influencing developing brain cells in utero [73, 74].
In general, it can be said that diabetes during pregnancy disrupts the develop-
ment, function, and maturity of the CNS in the children of diabetic mothers, which 
manifests itself in the form of intelligence, educational and behavioral problems. 
It should be noted that both increase and decrease in blood sugar during brain 
development can lead to a decrease in various cognitive functions [64, 65, 75].
1.2.3.7 Intelligence and memory disorders
Children born to diabetic mothers suffer from neuropsychiatric disorders, 
including decreased intelligence and memory disorders. In 1997, Rizzo and col-
leagues followed 139 women with gestational diabetes and reported that their chil-
dren’s intelligence was directly related to maternal glucose metabolism in the second 
and third trimesters of pregnancy [76]. In animal studies, the hippocampus, which 
is particularly involved in memory, has been identified as the most susceptible area 
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to the negative effects of hypoglycemia, which can occur in the fetus or immediately 
after birth. Overall, the results of various studies indicate the negative impact of 
maternal diabetes on cognitive functions, which can cause memory and intelligence 
deficits [75, 77, 78].
1.3 Effects diabetes during pregnancy on hippocampus
As mentioned before, the hippocampus is an important brain structure crucial 
for spatial learning and memory. In diseases that cause memory loss and other 
intellectual functions, such as Alzheimer’s disease, hippocampus cells are among 
the first cells to undergo degenerative changes. it is well documented that the 
hippocampus provides a stimulus that converts short-term memory to long-term 
memory, and whatever its mechanism, it would not have happened without the 
hippocampus [3].
Studies have shown hippocampus is very sensitive to changes in glucose con-
centration during development. in this regard, there is a bulk of studies that show 
children born to diabetic mothers are more likely to have neurodevelopmental 
abnormalities including impairments in memory, learning ability, activity level, 
attention span, and motor functioning. These infants also show lower IQ scores 
compared to infants born to healthy mothers [37, 58].
When pregestational and gestational diabetes-exposed children were grouped 
together in the study of DeBoer et al., it was demonstrated a negative link between 
maternal diabetes and development of memory, circuitry, and behavioral mne-
monic performance in children at 1-year of age. Moreover, they showed that the 
metabolic abnormalities due to diabetes during pregnancy alters prenatal develop-
ment, which can influence memory performance on a delay recall task. It is well 
documented that metabolic abnormalities which occur in diabetes during preg-
nancy can impair fetal CNS development, which leads to structural and functional 
defects, especially in the hippocampus [79].
Experimental models of diabetes during pregnancy in animals have shown a 
decrease in the numerical density of neurons in some parts of the fetal CNS, par-
ticularly in the hippocampus, which is reflected in decreased memory and learning 
and impaired memory storage and recall of information [37].
In the study by Sadeghi et al., stereological change in the hippocampus of rat 
offspring due to diabetes in pregnancy was evaluated. In that study, the authors 
found a significant reduction in total volumes of the hippocampus in offspring born 
to diabetic mothers when compared to the control group. In addition, their results 
have been shown the hippocampal subfields volumes, especially the CA1, DG, and 
subiculum, were significantly decreased. Moreover, they reported a significant 
decrease in the number of hippocampal cells in infants born to diabetic moth-
ers [80].
A study by Tehranipour and Khakzad examines the effect of maternal diabetes 
on neural density in the hippocampus of newborn rats immediately after birth. 
Their results showed that diabetes during pregnancy can decrease the number of 
neurons in the hippocampus, especially in the CA3 area [81].
Synaptogenesis is one of the key events which happen throughout the develop-
ment of the central nervous system. The chemical synapses in the central nervous 
system contain the presynaptic apparatus, the synaptic cleft, and the postsynaptic 
region. During synaptic transmission, In the presynaptic part, neurotransmit-
ters stored in the synaptic vesicle through the exocytosis process, release into the 
synaptic cleft and then fuse with their receptors in the postsynaptic membrane. 
This process is highly regulated in CNS. The bulk of studies were performed to 
recognize and specify the components of the synaptic vesicle membrane. These 
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studies have been found several proteins, including synaptophysin, synaptobrevin, 
and synaptogamin that functions as the regulators of exocytosis. In recent studies, 
synaptophysin has been utilized as a valid marker for synaptic density and synapto-
genesis [66, 82, 83].
In a study by Vafaei-Nezhad et al., researchers revealed that the SYP expres-
sion levels were significantly reduced in hippocampus sub-regions of pups born to 
diabetic animals, especially at P7 and P14, compared with the control group [66]. 
SYP as a major protein of the synaptic vesicle membrane may play an important 
role in transmitter release. Thus, the early decrease in SYP expression may reflect 
a down-regulation of synaptic functions and may be related to the release of 
the neurotransmitters. Since SYP and other synaptic vesicle proteins have been 
implicated in the mechanisms of cellular plasticity underlying learning, a decrease 
in the expression of this protein might disrupt memory formation [84–86]. SYP 
is also a reliable indicator of synaptic plasticity, and has previously been demon-
strated to correlate well with the loss of cognitive function in animal models with 
neurodegeneration and in humans with Alzheimer’s disease [87]. Earlier study also 
demonstrated a correlation between aging-related deficits in cognitive functions 
and disturbances in SYP expression in the hippocampus. There are also documents 
showing that upregulation of SYP expression may contribute to the mechanisms 
that underlie learning and memory [85, 86].
In another investigation by Sadeghi et al., the effects of maternal diabetes 
on neurogenesis in the developing hippocampus were examined. in the study, 
researchers probe NeuN and DCX markers changes. They found a significant higher 
mean number of DCX-positive cells and an up-regulation in mRNA expression of 
DCX in neonates born to diabetic mothers. Moreover, they demonstrated a signifi-
cant reduction in the mean number of NeuN-positive cells and down-regulation in 
NeuN expression in the newborns to diabetic animals [88].
This author in another study also revealed that maternal diabetes could result 
in developmentally induced increase in the hippocampal GFAP expression and 
numerical density of GFAP positive cells in the DG hippocampal subfield of the 
offspring born to diabetic mothers compared to healthy mothers [89].
In experimental animals, it is reported that diabetes during pregnancy can 
increase apoptosis in the central nervous system in neonates. In this context, 
research by Lotfi et al. revealed that maternal diabetes in newborns of diabetic 
mothers leads to a marked increase in the number of apoptotic cells in the CA3 
subregion of the hippocampus. They also suggested that hyperglycemia during 
pregnancy could cause a developmental change in the density of neuronal cells in 
the offspring’s hippocampus [90]. In consist with this study, in another research 
has been reported that diabetes during pregnancy leads to up-regulate in Bax and 
down-regulated in Bcl-2 gene expression (apoptosis-regulatory genes) in the hip-
pocampus of rat neonates born to mothers with diabetes [91].
Nowadays, neurotrophic factor such as brain-derived neurotrophic factor 
(BDNF) is considered for its role in regulating the development of the fetal nervous 
system. In the experiment by Sardar et al., they assessed the effects of maternal 
diabetes on gene expression and distribution pattern of BDNF in the hippocampus 
of neonatal rats. The results of the present study showed that diabetes during 
pregnancy causes marked BDNF downregulation and numerical density of BDNF+ 
cells reduction in both sides’ hippocampi of the male/female diabetic group [92].
In another study by Hami et al., the effects of diabetes in pregnancy on gene 
expression and protein concentration of IGF1R and IR in the developing rat hip-
pocampus at postnatal days 0, 7, and 14 were evaluated. In that study, the authors 
found a markedly upregulation of both IR and IGF1R expression in the hippocam-
pus of diabetic group newborns at first postnatal day. At the same time point, they 
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showed only slight changes in their hippocampal protein transcripts. In 7-day, old 
rats, there was a significant decreased in IGF-1R gene expression and protein levels 
in the newborns born to diabetic dams. Moreover, they found a down regulation in 
hippocampal IGF1R transcripts in 14-day old diabetic group offspring. Two weeks 
after birth, the IR gene expression was significantly declined in the hippocampus of 
diabetic newborns [18].
1.4 Effects diabetes on the hippocampus in adults
A bulk of studies have been demonstrated that all types of diabetes have adverse 
effects on the central nervous system such as disruption in hypothalamic and 
hippocampal neuropeptides gene expression, a change in hippocampal function 
and decreased hippocampal synaptic plasticity, glutamate neurotransmission 
abnormalities, and neurotoxicity [93, 94]. Studies have shown that people with 
diabetes have a higher risk of developing memory and learning disorders and also 
Alzheimer’s disease, depression, stroke, and dementia compared to healthy people 
[95]. A previous study showed that diabetes induction in animal models can elevate 
corticosterone levels and defects hippocampal synaptic plasticity, learning, and 
long-term potentiation in the CA1-field [96, 97]. Recent studies showed that STZ-
induced diabetes notably decreased the number of proliferating cells in the dentate 
gyrus of rats by changing the hippocampal synaptic plasticity [98].
There is some evidence that diabetes can decrease hippocampal cell proliferation 
and survival, while some researchers suggest that diabetes also has adverse effects 
on neuronal differentiation. Several preclinical studies revealed the bulk of evi-
dence that diabetes has adverse effects morphological integrity of the hippocampus 
and that it reduced hippocampal neurogenesis. These hippocampal dysfunctions 
may cause cognitive and mood disorders in diabetic’s people [99].
In the study by Revsin et al., Neuronal and astroglial alterations in the hip-
pocampus of a mouse model for type 1 diabetes have been evaluated. Their results 
showed that diabetic condition in mice can cause a significant increase in the 
number of astrocytes positive for apolipoprotein-E (Apo-E), a marker of ongoing 
neuronal dysfunction, abnormal expression of Jun + neurons in CA1 and CA3 
layers and dentate gyrus, and Fos-expressing neurons in CA3 layer, and augmented 
activity of NADPH-diaphorase which is linked to oxidative stress, in CA3 region. 
They state that these changes could be one of the reasons for the negative effects of 
diabetes on the hippocampus [94]. Similar to the results of this study Stereological 
studies have shown that there is no significant change in the total neuron number 
values and the volume of the hippocampus in diabetic animals compared to healthy 
animals [94, 100].
It is well known that type 2 diabetes mellitus can lead to cognitive deficits in 
patients. In this regard, a study by Liu et al., has been revealed that diabetes could 
alter effective connectivity (EC) between hippocampus and default mode network 
(DMN), which is interpreted to be related to cognitive disorders in patients with 
T2DM especially affecting learning and memory [101].
In experimental animals by Kamal et al., they assessed Synaptic transmis-
sion changes in diabetic rat s’ hippocampus. Their data illustrated that intracel-
lular recording from the pyramidal hippocampal cells of the AMPA summation 
responses in the diabetic animals was markedly lower than control animals. Hence, 
they suggest that diabetes can change pre and postsynaptic cells functions which 
may play a key role in in the synaptic plasticity disorder observed in diabetic 
animals [93].
Defects in glucose metabolism in the nervous system are not only important for 
neural cells function but also normal astrocyte activity is related to it. Astrocytes 
11
The Impact of Diabetes on Hippocampus
DOI: http://dx.doi.org/10.5772/intechopen.99895
have many important roles in central nervous system such as glucose uptake. 
Astrocyte dysfunction in the hippocampus have been seen in pathological condi-
tions such as aging, stress, autoimmune diseases, neurodegenerative diseases, and 
diabetes. In the hippocampus of the animal diabetic model has been reported a sig-
nificant increase in GFAP immunoreactivity, glial fibrillary acidic protein (GFAP), 
an astrocyte intermediate filament cytoskeletal protein which is considered the 
main indicator of astroglial activation caused by CNS injury [102]. In line with this 
study, a study by Lebed et al. showed that diabetes can alter GFAP and S100B levels 
in the hippocampus. These findings propose that the reaction of astroglial cells 
can be the first reaction to impaired glucose metabolism, which is likely to play a 
crucial role in the mechanisms underlying diabetes-related disorders of CNS func-
tion. [103].
In a study by Pamidi et al., the Effect of streptozotocin-induced diabetes on 
rat hippocampus was assessed. They used Cresyl violet staining for evaluating the 
number of surviving neurons in the subfield of the hippocampus. Their findings 
revealed that the number of survived neurons in the subfield of the hippocampus 
(CA1, CA2, CA3, dentate hilus, dentate gyrus) in diabetic animals was significantly 
reduced compared to controls. Hence, researchers suggested that uncontrolled and 
long-term diabetes could cause intense hippocampal neurodegeneration [104].
In another study, researchers examined the effects of STZ-induced diabetes on 
NCAM protein expression in various parts of the nervous system, including the hip-
pocampus. The results of this study have been demonstrated that diabetic animals 
developed remarkable defects in learning and memory behaviors which were 
evaluated by passive avoidance and water maze tests. Their results also indicate that 
streptozotocin-induced diabetes disrupts cognitive functions and causes an imbal-
ance in NCAM expression in some parts of the brain, particularly the hippocampus, 
which is involved in memory and learning. Based on the results of their study, the 
researchers concluded that changes in the expression of NCAM in the hippocampus 
of diabetic people could be one of the main causes of memory and learning disor-
ders [105].
Axonal transport has a critical role in normal CNS function and disruption of 
this process has been linked to various neurodegenerative diseases and could also 
play a role in diabetes-related diseases that affect the nervous system. Given the 
importance of this process, Baptista et al. assessed the impact of diabetes on axonal 
transport in the hippocampus. in this regard, they evaluated KIF1A, KIF5B, and 
dynein in the hippocampus. Their results showed a significant increase in KIF1A 
and KIF5B mRNA and protein levels, in CA1, CA3, and DG hippocampal sub-
region, in the diabetic animals. Nevertheless, no changes in dynein protein were 
observed [106].
The animal experiment has been revealed that diabetes can cause a reduction 
of nuclear and perikaryon diameters as well as neuronal density in the sub-region 
of the hippocampus (CA1, CA2, CA3, and dentate gyrus) [107]. In addition, it has 
been reported that levels of Caspase-3, Bax, and Bcl-2 in the hippocampus increase 
after diabetes [108].
1.5 Effects of diabetes during pregnancy on the other parts of CNS
The source of the mammalian neural tube is the ectoderm layer in the embryo. 
During the first few months of pregnancy which is called the embryonic period, 
part of the ectoderm becomes a neural plate. Then, this plate is folded, raised, 
and connected in the midline, which becomes the neural tube [109, 110]. The 
mentioned procedure is mediated by several signaling molecules and transcription 
elements [111, 112]. There is strong evidence that diabetes during pregnancy causes 
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abnormalities in the development of the nervous system, including the neural tube, 
which itself can cause neural tube defects (NTD) [113, 114]. Neural tube formation 
during the embryogenesis period is tightly regulated by several cellular mechanisms 
such as proliferation, migration, differentiation, and apoptosis of neural progeni-
tor cells. Previous studies have shown that pregnancy-related hyperglycemia can 
disrupt cell migration and proliferation, as well as induce programmed cell death 
during embryogenesis. Studies have revealed that any changes in the mentioned 
processes can cause NTDs [95, 115].
Spina bifida, which is one of the common NTD, results from failure of neural 
tube fusion in the spinal area. This abnormality is a common congenital defect that 
occurs in infants of diabetic mothers [116]. The exact mechanism underlying the 
teratogenic effects of diabetes during pregnancy is not entirely understood, but it 
is suggested that the incidence and intensity of congenital malformations in infants 
born to diabetic mothers are correlated with the degree of maternal metabolic 
control [37].
Diabetes during pregnancy causes biological changes in the mother that can 
affect the development of the fetal nervous system. These biological changes can 
affect nervous system development and neurological abnormalities in the fetus by 
affecting neurotransmitters, synaptic membranes, and the expression of growth 
factors that are involved in nervous system development. Studies have shown that 
increased oxidative stress plays an important role in fetal development and indi-
rectly can cause some of the nervous system developmental disorders that occur in 
fetuses from diabetic mothers [22]. Free radicals can also alter the biological activity 
of proteins and peptides, increase neuronal death, and cause DNA damage [37, 
117, 118]. Experimental research showed that maternal hyperglycemia can lead to a 
significant decrease in the volume of gray and white matter, and also can reduce the 
number of neurons in the gray matter of the CNS in this offspring [119].
Evaluations of cognitive functioning and the behavior of the children born to 
diabetic mothers provide the chance to functionally assess the CNS development. 
Hence, behavioral and cognitive assessments in neonates of diabetic mothers can 
shed light on the effects of maternal diabetes on CNS development [64, 65, 72, 73].
Animal models of diabetes during pregnancy indicate a decrease in the 
numerical density of neurons in some parts of the fetal central nervous system, 
particularly in the brain, hippocampus, and cerebellum, due to diabetes during 
pregnancy, which may be followed by decreased memory and learning ability, and 
memory defects and information retrieval [37, 58, 80, 120]. Studies by Khaksar 
on gestational diabetes have shown that gestational diabetes can affect the infant 
CNS and reduce the number of cells and the thickness of the white and gray matter 
of the infant cerebrum, cerebellum and spinal cord [119]. Earlier research on the 
neurologic development in infants of diabetic mothers illustrated fundamental CNS 
deficits even when there were no structural abnormalities. These alterations were 
markedly less serious when maternal diabetes was controlled and treated, but some 
alterations in cognitive function may continue all over childhood [37].
The study by Hami et al. showed that diabetes during pregnancy in infants 
born to diabetic mothers can lead to a significant decrease in cerebellar volume, the 
thickness of cerebellar cortical layers, and also decreases in the numerical densi-
ties of cerebellar Purkinje and granular cells. They suggested that this event may 
delay the normal development of the cerebellum and may be a cause of the motor, 
behavioral, structural, and cognitive disorders seen in the offspring of diabetic 
mothers [120].
It is well documented that diabetes during pregnancy has structural and func-
tional effects the on central nervous system in both human and animal studies. 
Despite much research in the field, the exact mechanism by which diabetes affects 
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the development of the nervous system during pregnancy is not yet clearly under-
stood. Some studies have suggested that diabetes itself may have teratogenic effects 
that can increase the risk of abnormal fetal development in the fetal organs [37].
Some studies suggested that hyperglycemia conditions during pregnancy can 
induce programmed cell death and impair cell proliferation in mouse embryo 
neural tubes. Recent experiments suggest that tumor necrosis factor (TNF) plays an 
important role in neurodevelopmental disorders in babies born to diabetic mothers. 
TNF could cross the placenta and enter the embryo’s bloodstream, which has neu-
rotoxic effects on fetal brain development and can also lead to white matter damage 
and cerebral palsy [35, 121].
Other investigations implicated that infants born to diabetic mothers have iron 
metabolism abnormalities. This deficiency can lead to neurodevelopmental and 
neurobehavioral disorders. Experimental studies in animal models have shown 
that iron impairment during pregnancy and after childbirth has negative effects on 
myelination, the metabolism of neurotransmitters in the brain, and the regulation 
of brain energy. The perinatal iron disorder can elevate the vulnerability of the 
neonatal brain, especially the hippocampus, to the hypoxic–ischemic insult which 
leads to abnormal cognitive processing in the newborn period [122, 123].
Kinney et al. found that the only female offspring born to diabetic dams showed 
deficits in long-term memory and learning. These results have suggested that the in 
utero diabetic condition has gender-specific effects on CNS development [78]. In a 
study by Plagemann et al., alterations in catecholamines levels in the hypothalamic 
nuclei of newborns born to diabetic animals were evaluated. They reported an 
increased hypothalamic dopamine (DA) and norepinephrine (NE) concentra-
tions in the offspring born to diabetic rats at birth. Twenty-one day- old pups 
born to diabetic mothers, NE levels were strikingly increased in the ventromedial 
hypothalamic nucleus and the lateral hypothalamic area (LHA), while DA levels 
were significantly elevated in the paraventricular hypothalamic nucleus and the 
LHA. The authors concluded that there are strikingly differences in hypothalamic 
catecholaminergic systems during early development in the rat newborns born to 
diabetic animals [124].
Studies have shown that brain weight in infants born to diabetic mothers is sig-
nificantly lower than in infants born to healthy mothers [66]. Interestingly, Xiang et 
al. explained a close correlation between diabetes during pregnancy with an elevated 
risk of autism spectrum disorder (ASD) in infants [125]. Animal models of diabetes 
during pregnancy indicate a decrease in the numerical density of neurons in some 
parts of the fetal central nervous system, particularly in the brain, hippocampus, and 
cerebellum, due to diabetes during pregnancy, which may be followed by decreased 
memory and learning ability, and memory defects and information retrieval [37, 58].
Much research has shown that fetal hyperglycemia during pregnancy can alter 
gene expression that is involved in the proliferation and differentiation of nerve 
cells. These changes can be the basis of the neurocognitive and neurodevelopmental 
disorders seen in babies of diabetic mothers [37, 58].
Previous studies have shown that insulin and insulin receptor (InsR), and 
insulin-like growth factor-1 (IGF-I) and IGF-1 receptor (IGF-1R) play key roles 
in regulating the growth and development of the CNS. It is well documented that 
insulin and IGF-1 stimulate the proliferation of neuronal progenitor cells, increases 
the survival of neurons and oligodendrocytes, elevate synaptogenesis and neurotic 
outgrowth, inhibit neural cell apoptosis, and induces differentiation of neurons. 
With this in mind, the researchers examined the effects of maternal diabetes on the 
expression of this factor in the nervous system. Their results have been revealed that 
maternal diabetes can strongly influence the regulation of these factors at the level 
of mRNA and protein in neonates’ central nervous system [18, 37, 58, 126, 127].
Hippocampus - New Advances
14
Synaptic transmission and information transfer are highly regulated processes 
in the nervous system. Information transfer occurs when neurotransmitters stored 
in synaptic vesicles release into the synaptic cleft and attach to their receptors in 
the postsynaptic cell membrane. Synaptic vesicles are responsible for collecting 
neurotransmitters and releasing them into the synaptic cleft through exocytosis. 
The exocytosis process during the release of neurotransmitters has been extensively 
studied [82, 83]. Several families of proteins that are present in the membranes of 
synaptic vesicles which involved in the regulation of this process have been identi-
fied [82]. One of these proteins is synaptophysin. This protein is widely found in the 
membranes of vesicles containing neurotransmitters in neurons.
Synaptophysin is a protein involved in the construction of synaptic vesicles 
that researchers use as a suitable marker of synaptic density, synaptogenesis [128]. 
Studies have also shown that synaptophysin may be involved in the exocytosis of 
synaptic vesicles [129]. It is well documented that synaptophysin levels also change 
in pathological brain conditions such as Alzheimer’s, Parkinson’s, schizophrenia, 
and bipolar disorder [87, 130–132]. Previous studies illustrated that diabetes during 
pregnancy can reduce significantly downregulate synaptophysin gene expression in 
different layers of the neonate cerebellum which is born to diabetic mothers [74].
2. Conclusions
As the prevalence of diabetes increases in various societies, particularly in devel-
oping countries, the total number of fetuses born to diabetic mothers will continue 
to increase in the coming decades. The metabolic changes caused by maternal 
diabetes disrupt glucose homeostasis in the fetus and cause numerous problems 
for the fetus. Nowadays, these metabolic disorders are discussed in various studies. 
Previous studies have clearly shown an association between maternal blood sugar 
levels and an increased risk of birth defects. Researchers have found that maternal 
hyperglycemia can have teratogenic effects on fetuses. However, the exact mecha-
nism of the cause of the malformations in the fetuses of diabetic mothers is not yet 
known. It is well documented that diabetes during pregnancy has significant effects 
on fetal central nervous system development, particularly the hippocampus, which 
can lead to disorders in learning, memory, and attention in newborns and adults. In 
this regard, it is suggested that suitable management of hyperglycemia and dissect-
ing out the mechanisms responsible for diabetes-related changes in the functions of 
the hippocampus, could help to prevent impaired cognitive and memory functions 
in offspring and adults.
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